Evidence map›Paper›PMID 32350921›Full record

ArticleThe EMBO journal2020

Cyclin A triggers Mitosis either via the Greatwall kinase pathway or Cyclin B.

Nadia Hégarat, Adrijana Crncec, Maria F Suarez Peredo Rodriguez, Fabio Echegaray Iturra, Yan Gu, Oliver Busby, Paul F Lang, Alexis R Barr, Chris Bakal, Masato T Kanemaki and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Countervailing effects of cyclin isoforms A and B during mitosis.bioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Nadia Hégarat *Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK.
Adrijana Crncec *Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK.ORCID 0000-0003-2076-1707
Maria F Suarez Peredo RodriguezGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK.ORCID 0000-0003-4414-0673
Fabio Echegaray IturraGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK.ORCID 0000-0002-0631-6896
Yan GuGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK.
Oliver BusbyGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK.
Paul F LangDepartment of Biochemistry, University of Oxford, Oxford, UK.
Alexis R BarrMRC London Institute of Medical Science, Imperial College, London, UK.ORCID 0000-0002-6684-8114
Chris BakalInstitute for Cancer Research, Chester Beatty Laboratories, London, UK.
Masato T KanemakiNational Institute of Genetics, Research Organization of Information and Systems (ROIS), Mishima, Japan.
Angus I LamondCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK.ORCID 0000-0001-6204-6045
Bela NovakDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID 0000-0002-6961-1366
Tony LyWellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-8650-5215
Helfrid HocheggerGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK.ORCID 0000-0001-8366-6198
University of Sussex · GBInstitute of Cancer Research · GBNational Institute of Genetics · JPNIHR Imperial Biomedical Research Centre · GBUniversity of Dundee · GBUniversity of Oxford · GBWellcome Centre for Cell Biology · GB

Funding

Cancer Research UK 14499Cancer Research UK 25729Medical Research Council MC_UP_1605/8Wellcome Trust 206211/Z/17/Z
6 · The paper itself

Abstract

Two mitotic cyclin types, cyclin A and B, exist in higher eukaryotes, but their specialised functions in mitosis are incompletely understood. Using degron tags for rapid inducible protein removal, we analyse how acute depletion of these proteins affects mitosis. Loss of cyclin A in G2-phase prevents mitotic entry. Cells lacking cyclin B can enter mitosis and phosphorylate most mitotic proteins, because of parallel PP2A:B55 phosphatase inactivation by Greatwall kinase. The final barrier to mitotic establishment corresponds to nuclear envelope breakdown, which requires a decisive shift in the balance of cyclin-dependent kinase Cdk1 and PP2A:B55 activity. Beyond this point, cyclin B/Cdk1 is essential for phosphorylation of a distinct subset of mitotic Cdk1 substrates that are essential to complete cell division. Our results identify how cyclin A, cyclin B and Greatwall kinase coordinate mitotic progression by increasing levels of Cdk1-dependent substrate phosphorylation.

Indexed as

MitosisCDC2 Protein KinaseCell LineCyclin ACyclin BHumansProtein Phosphatase 2CDC2 Protein KinaseCDK1 protein, humanCyclin ACyclin BProtein Phosphatase 2Cdk1CyclinGreatwallMASTLPP2A

Identifiers

PMID32350921
PMCPMC7265243
OpenAlexW3021664116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.